| Evosep ApS. (6/2/25). "Press Release: Evosep Unveils New Instrumentation and Partnership at ASMS 2025ASMS 2025". Baltimore, MD. |
2025-06-02 |
| GlycoEra AG. (5/27/25). "Press Release: GlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases". Newton, MA & Wädenswil. |
2025-05-27 |
| Augustine Therapeutics N.V.. (5/21/25). "Press Release: Augustine Therapeutics Appoints Rie Schultz Hansen, PhD, as Chief Scientific Officer and Establishes Copenhagen-based Subsidiary". Leuven. |
2025-05-21 |
| Novo Holdings A/S. (4/24/25). "Press Release: Novo Holdings and EIFO Invest €48 Million in HealthCap IX to Strengthen the Nordic Life Sciences Ecosystem". |
2025-04-24 |
| ExpreS2ion Biotech Holding AB. (4/15/25). "Press Release: ExpreS2ion Signs Letter of Intent with WuXi Vaccines to Initiate Technology Evaluation of ExpreS2ion’s Proprietary Production Platform ExpreS2". Hørsholm. |
2025-04-15 |
| ExpreS2ion Biotech Holding AB. (4/1/25). "Press Release: ExpreS2ion Provides Pipeline Update". Hørsholm. |
2025-04-01 |
| Augustine Therapeutics N.V.. (3/24/25). "Press Release: Augustine Therapeutics Raises Oversubscribed EUR 78 Million / USD 85 Million Series A Financing Round". Leuven. |
2025-03-24 |
| Roche. (3/12/25). "Press Release: Roche Enters into an Exclusive Collaboration & Licensing Agreement with Zealand Pharma to Co-develop and Co-commercialise Petrelintide as a Potential Foundational Therapy for People with Overweight and Obesity". Basel. |
2025-03-12 |
| Zealand Pharma A/S. (3/12/25). "Press Release: Zealand Pharma and Roche Enter Collaboration and License Agreement to Co-develop and Co-commercialize Petrelintide as a Future Foundational Therapy for People with Overweight and Obesity". Copenhagen. |
2025-03-12 |
| Adcendo ApS. (2/26/25). "Press Release: Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02". Copenhagen. |
2025-02-26 |
| Fuse Vectors ApS. (2/25/25). "Press Release: Fuse Vectors Secures $5.2m to Advance Cell-free Gene therapy Technology, Led by HCVC". Copenhagen. |
2025-02-25 |
| Evaxion Biotech A/S. (1/31/25). "Press Release: Evaxion Announces Closing of $10.8 Million Public Offering". Copenhagen. |
2025-01-31 |
| Evaxion Biotech A/S. (1/30/25). "Press Release: Evaxion Announces Pricing of $10.8 Million Public Offering". Copenhagen. |
2025-01-30 |
| Evaxion Biotech A/S. (1/28/25). "Press Release: Evaxion Granted 180-day Compliance Extension by Nasdaq as It Restores Equity above Minimum Requirement". Copenhagen. |
2025-01-28 |
| Forbion Capital Partners. (1/27/25). "Press Release: Forbion BioEconomy Fund I Surpasses €150 Million Target, Raising €164.5 Million with Strong Institutional LP Support". Naarden. |
2025-01-27 |
| Arctic Therapeutics. (1/22/25). "Press Release: Arctic Therapeutics Announces €26.5M Oversubscribed Series A Financing". Reykjavik & Philadelphia, PA. |
2025-01-22 |
| Coave Therapeutics (Horama S.A.). (1/9/25). "Press Release: Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines". Paris. |
2025-01-09 |
| Neumirna Therapeutics ApS. (1/8/25). "Press Release: Neumirna Therapeutics secures €20M in Series A financing to develop RNA therapies for epilepsy and other neurological disorders". Copenhagen. |
2025-01-08 |
| Argobio SAS. (1/7/25). "Press Release: Next-generation RNA Company Inverna Therapeutics Launched by Argobio and University of Southern Denmark". Odense. |
2025-01-07 |
| Orbis Medicines ApS. (1/6/25). "Press Release: Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles". Copenhagen. |
2025-01-06 |
| SiteOne Therapeutics, Inc.. (12/18/24). "Press Release: SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-opioid Treatments for Pain". South San Francisco, CA. |
2024-12-18 |
| Evaxion Biotech A/S. (12/17/24). "Press Release: Evaxion Pursues Agreement with EIB to Bolster Equity through Conversion of Debt into Equity". Copenhagen. |
2024-12-17 |
| Muna Therapeutics ApS. (12/5/24). "Press Release: Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease". Copenhagen. |
2024-12-05 |
| Antag Therapeutics ApS. (12/4/24). "Press Release: Antag Therapeutics Announces €80 Million Series A Financing". Copenhagen. |
2024-12-04 |
| H. Lundbeck A/S. (11/18/24). "Press Release: Lundbeck Announces Expiration of Longboard Tender Offer and That All Tender Offer Conditions Are Fulfilled". |
2024-11-28 |
| Acadia Pharmaceuticals Inc.. (11/26/24). "Press Release: Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711". San Diego, CA. |
2024-11-26 |
| Saniona AB. (11/26/24). "Press Release: Saniona Announces Licensing Agreement with Acadia Pharmaceuticals for SAN711 in Neurological Diseases". |
2024-11-26 |
| Adcendo ApS. (11/25/24). "Press Release: Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline". Copenhagen. |
2024-11-25 |
| Kivu Bioscience. (10/28/24). "Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates". San Francisco, CA. |
2024-10-28 |
| HepaRegenix GmbH. (10/22/24). "Press Release: HepaRegenix Appoints Dr. Martin Bonde as New Chair of the Board". Tübingen. |
2024-10-22 |
| H. Lundbeck A/S. (10/14/24). "Press Release: Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline". Valby & La Jolla, CA. |
2024-10-14 |
| Booster Therapeutics GmbH. (10/10/24). "Press Release: Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for the Treatment of a Range of Complex Diseases". Berlin. |
2024-10-10 |
| Evotec SE. (9/26/24). "Press Release: Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-generation Cell Therapies". Hamburg. |
2024-09-26 |
| NanoVation Therapeutics Inc.. (9/18/24). "Press Release: NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases". Vancouver, BC. |
2024-09-18 |
| Adcendo ApS. (8/20/24). "Press Release: Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor". Copenhagen & Shanghai. |
2024-08-20 |
| Bavarian Nordic A/S. (8/8/24). "Press Release: Bavarian Nordic Receives USD 156.8 Million from the U.S. Government for Additional Smallpox/Mpox Vaccine Production". Copenhagen. |
2024-08-08 |
| Draupnir Bio ApS. (7/1//24). "Press Release: Draupnir Bio Completes €12 Million Seed Round to Progress Development of Oral Small Molecule Degraders of Extracellular Proteins". Copenhagen. |
2024-07-17 |
| Asceneuron S.A.. (7/16/24). "Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases". Lausanne & San Francisco, CA. |
2024-07-16 |
| Myricx Pharma Ltd.. (7/8/24). "Press Release: Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development". London. |
2024-07-08 |
| Macomics Ltd.. (6/10/24). "Press Release: Macomics Announces Appointment of Simon Dew as New Chief Business Officer". Edinburgh & Cambridge. |
2024-06-10 |
| Adcendo ApS. (5/29/24). "Press Release: Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline". Copenhagen. |
2024-05-29 |
| Cellugy. (5/21/24). "Press Release: Danish Industrial Biotechnology Startup Cellugy Raises €4.9M to Replace Petrochemicals in Personal Care Products". Søborg. |
2024-05-21 |
| Single Use Support GmbH. (5/15/24). "Press Release: Novo Holdings Acquires Majority Stake in Single Use Support". Kufstein. |
2024-05-15 |
| H. Lundbeck A/S. (5/13/24). "Press Release: Maria Alfaiate Appointed New Executive Vice President Commercial and Corporate Strategy at Lundbeck". |
2024-05-13 |
| Commit Biologics ApS. (5/9/24). "Press Release: Commit Biologics Launches with €16m Seed Financing to Pioneer Complement System Activation to Treat Cancer and Autoimmune Disease". Aarhus. |
2024-05-09 |
| Genmab A/S. (4/3/24). "Press Release: Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio". Copenhagen & Seattle, WA. |
2024-04-03 |
| Cardior Pharmaceuticals GmbH. (3/25/24). "Press Release: Novo Nordisk to Acquire Cardior Pharmaceuticals and Strengthen Pipeline in Cardiovascular Disease". Bagsværd & Hannover. |
2024-03-25 |
| Fida Biosystems ApS. (3/13/24). "Press Release: In-Solution Kinetics by Fida Biosystems – Redefining Drug Interaction Analysis for Therapeutic Discovery". Copenhagen. |
2024-03-13 |
| Commit Biologics ApS. (2/14/24). "Press Release: Commit Biologics Receives Innobooster Grant from Innovation Fund Denmark Funding". |
2024-02-14 |
| Novonesis. (1/29/24). "Press Release: The Combination of Novozymes and Chr. Hansen Is Now Successfully Completed, Creating Novonesis – a Leading Global Biosolutions Partner". Copenhagen. |
2024-01-29 |
| Novo Nordisk A/S. (1/4/24). "Press Release: Novo Nordisk Enters into Research Collaborations with Omega Therapeutics and Cellarity on Novel Treatment Approaches for Cardiometabolic Diseases". Bagsværd, Cambridge, MA & Somerville, MA. |
2024-01-04 |
| Freya Biosciences. (12/12/23). "Press Release: Freya Biosciences Announces $38 Million Funding in One of the Largest Series A Raises to Advance Women’s Reproductive Immunotherapies". Copenhagen. |
2023-12-12 |
| NMD Pharma A/S. (11/15/23). "Press Release: NMD Pharma Raises €75 Million (~$80 million) in a Series B Financing". Aarhus. |
2023-11-15 |
| Lundbeckfonden. (10/16/23). "Press Release: Venture Forces Invest Millions in New Type of Treatment for Particularly Aggressive Form of Cancer". |
2023-10-16 |
| LimmaTech Biologics AG. (10/9/23). "Press Release: LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections". Schlieren. |
2023-10-09 |
| Evosep ApS. (9/28/23). "Press Release: Evosep Strengthens Leadership to Drive Scale-up". Odense. |
2023-09-28 |
| Acesion Pharma ApS. (9/26/23). "Press Release: Acesion Pharma Closes Oversubscribed €45M Series B Financing Round". Copenhagen. |
2023-09-26 |
| Novo Nordisk A/S. (9/25/23). "Press Release: Valo Health and Novo Nordisk to Collaborate to Discover and Develop Novel Treatments for Cardiometabolic Diseases Using Human Data and Artificial Intelligence". Bagsværd & Boston, MA. |
2023-09-25 |
| BioInnovation Institute (BII). (9/4/23). "Press Release: Six Companies Enter BioInnovation Institute’s Venture House Program Receiving Additional Financial Support". |
2023-09-04 |
| Embark Laboratories ApS. (8/30/23). "Press Release: Novo Nordisk Acquires Embark Biotech, including Its Lead Asset Targeting Obesity and other Cardiometabolic Diseases". Copenhagen. |
2023-08-30 |
| Novo Nordisk A/S. (8/10/23). "Press Release: Novo Nordisk to Acquire Inversago Pharma to Develop New Therapies for People Living with Obesity, Diabetes and other Serious Metabolic Diseases". Bagsværd & Montreal. |
2023-08-10 |
| Bactolife A/S. (8/8/23). "Press Release: Bactolife Raises EUR 30 Million in Series A Financing". Copenhagen. |
2023-08-08 |
| IO Biotech, Inc.. (8/7/23). "Press Release: IO Biotech, Inc. Announces $75 Million Private Placement Financing". New York, NY. |
2023-08-07 |
| Golgi Neurosciences S.r.l.. (7/25/23). "Press Release: Golgi Neurosciences and Breye Therapeutics Announce Successful Closing of P2X7 Receptor Antagonist program transfer". Milan & Copenhagen. |
2023-07-25 |
| Saniona AB. (7/17/23). "Press Release: Saniona Enters into Collaboration Agreement with AstronauTx in Alzheimer’s Disease". |
2023-07-17 |
| BioGeneration Ventures B.V.. (7/13/23). "Press Release: BioGeneration Ventures Closes BGV Fund V at €150 Million". Naarden. |
2023-07-13 |
| Freya Biosciences. (6/27/23). "Press Release: Freya Biosciences Announces Positive Topline Clinical Trial Results for FB101 in Women with Asymptomatic Vaginal Dysbiosis". Copenhagen. |
2023-06-27 |
| EQT AB. (6/21/23). "Press Release: EQT Private Equity to Sell Ellab, Following Transformation into a Leading Validation & Monitoring Provider for the Biotech and Pharmaceutical Industries". |
2023-06-21 |
| Qiagen N.V.. (6/13/23). "Press Release: Danish National Genome Center Selects Qiagen for Variant Interpretation in Oncology Genome Sequencing". Venlo & Redwood City, CA. |
2023-06-13 |
| IO Biotech, Inc.. (6/1/23). "Press Release: IO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior Vice President, Commercial and Program Lead". New York, NY. |
2023-06-01 |
| Adcendo ApS. (5/30/23). "Press Release: Adcendo ApS Announces Option License Agreement with Duality Biologics to Enhance Optionality to Further Expand First-in-class ADC Pipeline". Copenhagen. |
2023-05-30 |
| Argenx SE. (4/17/23). "Press Release: Argenx and Genmab Enter Partnership to Advance Antibody Therapies in Immunology and Oncology". Amsterdam. |
2023-04-17 |
| Adcendo ApS. (4/4/23). "Press Release: Adcendo ApS Announces Extension of Series A Financing to 82M EUR to Ensure Broad Development of its First-in-class ADC Pipeline". Copenhagen. |
2023-04-04 |
| PolyPeptide Group AG. (4/3/23). "Press Release: PolyPeptide Appoints Juan-José Gonzalez as CEO and Announces Change of CFO". Baar. |
2023-04-03 |
| AH Diagnostics A/S. (4/3/23). "Press Release: Helle Zacho Becomes the New CEO of the AH Diagnostics Group". |
2023-04-03 |
| Teitur Trophics ApS. (3/14/23). "Press Release: Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases". Aarhus. |
2023-03-14 |
| Hemab ApS. (2/21/23). "Press Release: Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders". Copenhagen & Boston, MA. |
2023-02-21 |
| Rewind Therapeutics. (1/25/23). "Press Release: Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor". Leuven. |
2023-01-25 |
| Evosep ApS. (1/9/23). "Press Release: Evosep Receives Strategic Investment from Novo Holdings A/S to Accelerate Its Effort on Clinical Proteomics". Odense. |
2023-01-09 |
| Adcendo ApS. (1/5/23). "Press Release: Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform". Copenhagen. |
2023-01-05 |
| Bactolife A/S. (1/4/23). "Press Release: Bactolife Appoints Sebastian Søderberg New CEO". Copenhagen. |
2023-01-04 |
| Adcendo ApS. (12/19/22). "Press Release: GlyTherix and Adcendo Announce Agreement for Development of Antibody Drug Conjugate". |
2022-12-19 |
| Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. |
2022-12-15 |
| Novozymes A/S. (12/12/22). "Press Release: Novozymes and Chr. Hansen to Combine and Create a Leading Global Biosolutions Partner [Not for US, CA, et al.]". Copenhagen. |
2022-12-12 |
| Novo Nordisk A/S. (11/22/22). "Press Release: Novo Nordisk Invests DKK 5.4 bn Danish Kroner in Expansion of Clinical Manufacturing Facilities in Bagsværd, Denmark". Bagsværd. |
2022-11-22 |
| Clinical Microbiomics A/S. (10/17/22). "Press Release: Clinical Microbiomics Acquire MS-Omics to Become Leading Multi-omics Provider for the Microbiome field". Copenhagen. |
2022-10-17 |
| Seventure Partners. (10/11/22). "Press Release: Clinical Microbiomics Set to Accelerate Its Expansion with EUR 10 Million Investment from Health for Life Capital II Managed by Seventure Partners". Paris & Copenhagen. |
2022-10-11 |
| Ventus Therapeutics, Inc.. (9/29/22). "Press Release: Ventus Therapeutics Enters Exclusive Development and License Agreement with Novo Nordisk for NLRP3 Inhibitor Program". Waltham, MA & Montréal, QC. |
2022-09-29 |
| Novo Nordisk Foundation. (9/21/22). "Press Release: Major Investment for Developing Denmark’s First Fully Functional Quantum Computer". |
2022-09-21 |
| Novo Nordisk A/S. (9/12/22). "Press Release: Novo Nordisk and Microsoft Collaborate to Accelerate Drug Discovery and Development Using Big Data and Artificial Intelligence". Bagsværd & Redmond, WA. |
2022-09-12 |
| Novo Nordisk A/S. (9/1/22). "Press Release: Novo Nordisk to Acquire Forma Therapeutics and Expand Presence in Sickle Cell Disease and Rare Blood Disorders". Bagsværd & Watertown, MA. |
2022-09-01 |
| BioInnovation Institute (BII). (8/22/22). "Press Release: BII Supports Three International Start-ups Developing Pioneering Science in the Therapeutics and Health Tech Space". |
2022-08-22 |
| SSI Diagnostica A/S. (8/22/22). "Press Release: SSI Diagnostica Continues Strong Growth Journey by Merging with Virginia-based TechLab". |
2022-08-22 |
| Adelis Equity Partners. (8/22/22). "Press Release: Adelis Equity Partners Raises Fund Continuation Vehicle for SSI Diagnostica Group, Enabling Transformational Acquisition". |
2022-08-22 |
| BioNTech SE. (8/5/22). "Press Release: BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates". Mainz & Copenhagen. |
2022-08-05 |
| ECBF Management GmbH. (7/7/22). "Press Release: ECBF Expands Its Industrial Biotech Portfolio to Offer Naturally Produced Vitamins". Luxembourg. |
2022-07-07 |
| FMC Corporation. (6/29/22). "Press Release: FMC Corporation Significantly Expands Biologicals Platform with Agreement to Acquire BioPhero". Philadeliphia, PA. |
2022-06-29 |
| Centogene N.V.. (6/27/22). "Press Release: Centogene Announces Appointment of Miguel Coego Rios as Chief Financial Officer". Cambridge, MA, Rostock & Berlin. |
2022-06-27 |
| Biotalys N.V.. (6/21/22). "Press Release: Biotalys and Novozymes Enter into Partnership to Expand Opportunities for Evoca". Ghent & Copenhagen. |
2022-06-21 |
| Synklino ApS. (6/8/22). "Press Release: Synklino Completes Series A Raise of EUR 29.8 Million to Advance Clinical Trials of Its Drug Candidate for the Treatment of Cytomegalovirus (CMV)". Copenhagen. |
2022-06-08 |
![[LSS] Life-Sciences-Scandinavia.com - The Scandinavian Life Sciences Web Portal](/images/basics/lss-life-sciences-scandinavia-portal-logo.svg){kind=logo}
Date
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px](/banner/iito-business-intelligence-20220406-650-300-lse-life-sciences-europe.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
